Reply to Anthony et al., "Protecting Pyrazinamide, a Priority for Improving Outcomes in Multidrug-Resistant Tuberculosis Treatment".
about
Reply to Anthony et al., "Protecting Pyrazinamide, a Priority for Improving Outcomes in Multidrug-Resistant Tuberculosis Treatment".
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Reply to Anthony et al., "Prot ...... stant Tuberculosis Treatment".
@en
type
label
Reply to Anthony et al., "Prot ...... stant Tuberculosis Treatment".
@en
prefLabel
Reply to Anthony et al., "Prot ...... stant Tuberculosis Treatment".
@en
P2860
P356
P1476
Reply to Anthony et al., "Prot ...... istant Tuberculosis Treatment"
@en
P2093
P2860
P356
10.1128/AAC.00427-17
P407
P577
2017-05-24T00:00:00Z